Медицинская литература. Новинки

 

 

 

 

 

 

Мелкоклеточный рак предстательной железы: три собственных наблюдения и обзор литературы

Вы можете загрузить полный текст статьи в формате pdf

Мелкоклеточный рак является редкой морфологической формой злокачественных опухолей предстательной железы, характеризуется агрессивным клиническим течением, склонностью к раннему метастазированию, андрогеннезависимостью и нечувствительностью к гормональной терапии. Приведены три собственных клинических наблюдения, иллюстрирующих картину мелкоклеточного рака предстательной железы и динамику его развития по данным МРТ таза и других лучевых методов исследования. Дан краткий обзор литературы.

Ключевые слова:
мелкоклеточный рак, предстательная железа, МРТ.

Литература:
1. Yashi M., Terauhi F., Ochi M. et al. Small cell neuroendocrine carcinoma as variant form of prostate cancer reccurence: А case report and short literature review. Urol.
Oncol. 2006; 24: 313–317.
2. Helpap B., Köllermann J., Oehler U. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol. Int. 1999; 62 (3): 133–138.
3. Wenk R.E., Bhagavan B.S., Levy R. et al. Ectopic ACTH,
prostatic oat cell carcinoma, and marked hypernatremia.
Cancer 1977; 40 (2): 773–778.
4. Aygun C. Small cell carcinoma of the prostate: a case
report and review of the literature. Md. Med. J. 1997;
46 (7): 353–356.
5. Oesterling J.E., Hauzeur C.G., Farrow G.M. Small cell
anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. Urology
1992; 147(3): 804–807.
6. Tetu B., Ro J.Y., Ayala A.G. et al. Small cell carcinoma of
the prostate. A clinicopatholologic study of 20 cases.
Cancer 1987; 59: 1803–1809.
7. Wang W., Epstein J.I. Small cell carcinoma of the prostate.
A morphologic and immunohistochemical study of 95
cases. Am. J. Surg. Pathol. 2008; 32 (1): 65–71.
8. TurbatHerrera E.A., Herrera G.A., Gore I., Lott R.L. et al.
Neuroendocrine differentiation in prostatic carcinomas:
a retrospective autopsy study. Arch. Pathol. Lab. Med.
1988; 112: 1100–1105.
9. Palmgren J.S., Karavadia S.S., Wakefield M.R. Unusual
and underappreciated: small cell carcinoma of the
prostate. Semin. Oncol. 2007; 34 (1): 22–29.
10. Cohen R.J., Glezerson G., Haffesie Z. et al. Prostatic carcinoma: histological and immunohistological factors
affecting prognosis. Br. J. Urol. 1990; 66: 405–410.
11. Jiborn T., Bjartell A., Abrahamsson P.A. Neuroendocrine
differentiation in prostatic carcinoma during hormonal
treatment. Urology 1998; 51(4): 585–589.
12. Asmis T.R., Reaume M.N., Dahrouge S., Malone S.
Genitourinary small cell carcinoma: a retrospective review
of treatment and survival patterns at The Ottawa Hospital
Regional Cancer Center. Br. J. Urol. Int. 2006; 97(4):
711–715.
13. Evans A.J., Humphrey P.A., Belanai J. et al. Lage cell neuroendocrine carcinoma of prostate: A clinicopatologic
summary of 7 cases of rare manifestation of advanced
prostate cancer. Am. J. Surg. Pathol. 2006; 30: 684–693.
14. Abbas F., Civantos F., Benedetto P., Soloway M.S. Small
cell carcinoma of the bladder and prostate. Urology 1995;
46: 617–630.
15. Франк Г.А. Морфология рака предстательной железы.
Практ. онкол. 2008; 9(2): 65–70.
16. Petraki C., Vaslamatzin M., Petraki K. et al. Prostate cancer with small cell morphology: An immunophenotypic
subdivision. Scand. J. Urol. Nephrol. 2005; 39: 455–463.
17. Mazzucchelli R., Morichetti D., LopezBeltran A. et al.
Neuroendocrine tumours of the urinary system and male
genital organs: clinical significance. Br. J. Urol. Int. 2009;
103 (11): 1464–1470.
18. Wu J. T., Astill M.E., Liu G.H. et al. Serum Chromogranin A:
early detection of hormonal resistance in prostate cancer
patient. J. Clin. Lab.Anal. 1998; 12 (1): 20–25.
19. Di Sant’Agnese P.A., Cockett A.T. The prostatic endocrineparacrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review
and future direction in basic research. J. Urol. 1994; 152:
1927–1031.
20. Patel A., Ball J., Chappell M. Pure small cell carcinoma of
the prostate. Br. J. Urol. 1993; 72: 380–381.
21. Brownback K.R,, Renzulli J., Delellis R., Myers J.R. Smallcell prostate carcinoma: A retrospective analysis of five
newly reported cases. Indian J. Urol. 2009; 25 (2):
259–263,
22. Rubenstein J.H., Katin M.J., Mangano M.M. et al. Small
cell anaplastic carcinoma of the prostate: seven new
cases, review of the literature, and discussion of a therapeutic strategy. Am. J. Clin. Oncol. 1997; 20 (4): 376–380.
23. Stein M.E., Bernstein Z., Abacioglu U. et al. Smoll cell
(neuroendocrine) carcinoma of the prostate: etiology,
diagnosis, prognosis and therapeutic implications – a retrospective study of 30 patients from the rare cancer network. Am. J. Med. Sci. 2008; 336 (6): 478–488.
24. Sasaki M., Kobayashi T., Ono K. et al. Small cell carcinoma
of the prostate: case report. Hinyokika Kiyo 2006; 52(9):
719–721.
25. Slovin S.F. Does small cell phenotype predict the natural
history of prostate cancer? A case study in disease behavior. Nat. Clin. Pract. Oncol. 2007; 4 (9): 551–554.
26. Tanaka M., Suzuki Y., Takaoka K. et al. Progression of
prostate cancer to neuroendocrine cell tumor. Int. J. Urol.
2001; 8: 431–436.

Small Cell Carcinoma of the Prostate: Report of Three Cases and Literature Review

Small cell carcinoma of the prostate is a rare pathologic subtype of prostate cancer; it is characterized by aggressive behavior course, association with early metastatic disease, androgen-independency and insensitivity to hormone therapy. We describe three cases, which illustrate imaging features of small cell carcinoma of the prostate and the progression of the disease which was estimated by pelvic MRI and others imaging methods. Brief literature review is given.

Keywords:
small cell carcinoma, prostate cancer, MRI.